Therapy: Rheumatic disease after immune checkpoint inhibitor therapy

被引：0
|
作者：
Ummarino D.
机构：
来源：
Nature Reviews Rheumatology | 2017年 / 13卷 / 8期
关键词：
D O I：
10.1038/nrrheum.2017.113
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：450 / 450
相关论文
共 50 条
  • [21] Sarcoidosis and Airway Disease After Immune Checkpoint Inhibitor Therapy: Case Study and Review of the Literature
    Soto, Felipe
    Torre-Sada, Luis F.
    Mott, Frank E.
    Kim, Sang T.
    Nurieva, Roza
    Nagarajan, Priyadharsini
    Guo, Ming
    Shannon, Vickie R.
    Faiz, Saadia A.
    Casal, Roberto F.
    Altan, Mehmet
    Lin, Julie
    Sheshadri, Ajay
    JOURNAL OF IMMUNOTHERAPY AND PRECISION ONCOLOGY, 2023, 6 (02)
  • [22] A Single Center Experience of Pneumonitis After Immune Checkpoint Inhibitor Therapy
    Heckman, A. J.
    Kwon, M.
    Arunthari, V.
    Lou, Y.
    Manochakian, R.
    Grage, R.
    Rojas, C.
    Patel, N. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [23] A Case of Ventricular Fibrillation Arrest After Immune Checkpoint Inhibitor Therapy
    Mckay, Kelly R.
    Jilani, Mohammad Hashim H.
    Moseley, Alex
    CIRCULATION, 2023, 148
  • [24] Response to a combination of erlotinib and bevacizumab therapy after immune checkpoint inhibitor
    Okauchi, Shinichiro
    Miyazaki, Kunihiko
    Yamada, Hideyasu
    Satoh, Hiroaki
    CLINICAL RESPIRATORY JOURNAL, 2020, 14 (05): : 500 - 501
  • [25] Immune checkpoint inhibitor therapy in patients with preexisting inflammatory bowel disease
    Abu-Sbeih, Hamzah
    Faleck, David
    Ricciuti, Biagio
    Mendelsohn, Robin
    Naqash, Abdul Rafeh
    Cohen, Justine
    Sellars, MacLean
    Balaji, Aanika
    Ben-betzalel, Guy
    Hajir, Ibraheim
    Zhang, Jiajia
    Awad, Mark
    Leonardi, Giulia
    Johnson, Douglas
    Pinato, David
    Owen, Dwight
    Weiss, Sarah
    Lamberti, Giuseppe
    Lythgoe, Mark
    Manuzzi, Lisa
    Arnold, Christina
    Qiao, Wei
    Naidoo, Jarushka
    Markel, Gal
    Powell, Nick
    Yeung, Sai-Ching
    Sharon, Elad
    Dougan, Michael
    Wang, Yinghong
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [26] Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease
    Abu-Sbeih, Hamzah
    Faleck, David
    Ricciuti, Biagio
    Mendelsohn, Robin
    Naqash, Abdul Rafeh
    Cohen, Justine
    Sellers, Maclean
    Balaji, Aanika
    Ben-Betzalel, Guy
    Hajir, Ibraheim
    Zhang, Jiajia
    Awad, Mark
    Leonardi, Giulia
    Johnson, Douglas
    Pinato, David
    Owen, Dwight
    Weiss, Sarah
    Lamberti, Giuseppe
    Lythgoe, Mark
    Manuzzi, Lisa
    Arnold, Christina
    Naidoo, Jarushka
    Merkel, Gal
    Powell, Nick
    Yeung, Sai-Ching
    Sharon, Elad
    Dougan, Michael
    Wang, Yinghong
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S451 - S451
  • [27] Prevalence and therapy of rheumatic immune-related adverse events due to immune checkpoint inhibitor therapy: A single-centre analysis
    Verspohl, S. H.
    Holderried, T.
    Behning, C.
    Brossart, P.
    Schaefer, V. S.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 193 - 194
  • [28] Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease
    Abu-Sbeih, Hamzah
    Faleck, David M.
    Ricciuti, Biagio
    Mendelsohn, Robin B.
    Naqash, Abdul R.
    Cohen, Justine V.
    Sellers, Maclean C.
    Balaji, Aanika
    Ben-Betzalel, Guy
    Hajir, Ibraheim
    Zhang, Jiajia
    Awad, Mark M.
    Leonardi, Giulia C.
    Johnson, Douglas B.
    Pinato, David J.
    Owen, Dwight H.
    Weiss, Sarah A.
    Lamberti, Giuseppe
    Lythgoe, Mark P.
    Manuzzi, Lisa
    Arnold, Christina
    Qiao, Wei
    Naidoo, Jarushka
    Markel, Gal
    Powell, Nick
    Yeung, Sai-Ching J.
    Sharon, Elad
    Dougan, Michael
    Wang, Yinghong
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06) : 576 - +
  • [29] Frequency of Relapse in Demyelinating Disease Following Immune Checkpoint Inhibitor Therapy
    Hasan, S.
    Zorio, O.
    Keegan, M.
    Weinshenker, B.
    Flanagan, E.
    Tobin, O.
    Kantarci, O.
    Toledano, M.
    Pittock, S.
    Lopez-Chiriboga, S.
    Zekeridou, A.
    Valencia-Sanchez, C.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 197 - 198
  • [30] EMERGING COMPLICATION OF IMMUNE CHECKPOINT INHIBITOR THERAPY
    Buntak, Vesna
    Loutoo, Ariane J.
    Joseph, Phillip
    CHEST, 2023, 164 (04) : 3177A - 3177A
12345